Volta Medical, a pioneering French-based HealthTech startup, has raised $28 million in a new funding round. The financing round was led by Gilde Healthcare with participation from existing shareholder Pasteur Mutualité.
Founded in 2016 by Julien Seitz, Théophile Mohr Durdez, and Clément Bars, Volta Medical is developing AI software solutions to assist cardiac electrophysiologists in the operating room. Volta is aimed to improve cardiac arrhythmia management by developing state-of-the-art, data-driven medical devices based on large databases of procedural data with the highest standards of data protection. Its first product, VX1, assists cardiologists in the real-time identification of specific abnormal electrograms, known as dispersed electrograms.
The new capital will allow the company to establish its revolutionary FDA-cleared and CE marked VX1 AI software solution as a new standard of care, pursue further R&D activities and start to roll out commercial activities across the US and Europe, the company writes.
